Delivery Order SPE2DB20D3103-SPE2DB25FP9E5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $7,389.26. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,759.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be performed from the contractor's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ondansetron HCl 4 mg tablets in quantities of 500 units, with a ceiling value of $5,252.73. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ondansetron HCl 4 mg tablets (30-count packaging) with a ceiling value of $25,134.02. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be performed and delivered from...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ondansetron HCl 4 mg tablets in quantities of 30, with a ceiling value of $8,454.17. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,931.21 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the...
- The Defense Logistics Agency awarded a delivery order valued at $5,996.73 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract does not include a set-aside designation. Performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 MG, with a ceiling value of $13,338.54 under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside provisions and has an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,466.96 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 count) under a firm fixed-price contract valued at $23,344.88. The contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9E5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in unit dose packages of 100 tablets, with a contract value of $7,800.96. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, under a firm fixed price arrangement. This is a non-set-aside award issued competitively. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 8/18/25 |